69 related articles for article (PubMed ID: 30453725)
1. [Research progress on pharmacokinetics and pharmacological activities of artesunate].
Cen YY; Zao YB; Li P; Li XL; Zeng XX; Zhou H
Zhongguo Zhong Yao Za Zhi; 2018 Oct; 43(19):3970-3978. PubMed ID: 30453725
[TBL] [Abstract][Full Text] [Related]
2. Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration.
Morris CA; Duparc S; Borghini-Fuhrer I; Jung D; Shin CS; Fleckenstein L
Malar J; 2011 Sep; 10():263. PubMed ID: 21914160
[TBL] [Abstract][Full Text] [Related]
3. Systematic review of artesunate pharmacokinetics: Implication for treatment of resistant malaria.
Kouakou YI; Tod M; Leboucher G; Lavoignat A; Bonnot G; Bienvenu AL; Picot S
Int J Infect Dis; 2019 Dec; 89():30-44. PubMed ID: 31491558
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetics and pharmacodynamics of the artesunate-mefloquine fixed dose combination for the treatment of uncomplicated falciparum malaria in African children.
Guidi M; Mercier T; Aouri M; Decosterd LA; Csajka C; Ogutu B; Carn G; Kiechel JR
Malar J; 2019 Apr; 18(1):139. PubMed ID: 30999915
[TBL] [Abstract][Full Text] [Related]
5. Murine pharmacokinetics and antimalarial pharmacodynamics of dihydroartemisinin trimer self-assembled nanoparticles.
Guo W; Li N; Ren G; Wang R; Chai L; Li Y; Wang X; Yang Q; Wang R; Zhang G; Yang L; Yi B; Zhang S
Parasitol Res; 2021 Aug; 120(8):2827-2837. PubMed ID: 34272998
[TBL] [Abstract][Full Text] [Related]
6. The Antimalarial Drug Artesunate Attenuates Cardiac Injury in A Rodent Model of Myocardial Infarction.
Khan AI; Kapoor A; Chen J; Martin L; Rogazzo M; Mercier T; Decosterd L; Collino M; Thiemermann C
Shock; 2018 Jun; 49(6):675-681. PubMed ID: 29757923
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of artesunate following oral and rectal administration in healthy Sudanese volunteers.
Awad MI; Eltayeb IB; Baraka OZ; Behrens RH; Alkadru AM
Trop Doct; 2004 Jul; 34(3):132-5. PubMed ID: 15267037
[TBL] [Abstract][Full Text] [Related]
8. Comparative pharmacokinetics and pharmacodynamics of intravenous artelinate versus artesunate in uncomplicated Plasmodium coatneyi-infected rhesus monkey model.
Teja-Isavadharm P; Siriyanonda D; Rasameesoraj M; Limsalakpeth A; Chanarat N; Komcharoen N; Weina PJ; Saunders DL; Gettayacamin M; Scott Miller R
Malar J; 2016 Sep; 15(1):453. PubMed ID: 27599723
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of oral artesunate in children with moderately severe Plasmodium falciparum malaria.
Bethell DB; Teja-Isavadharm P; Cao XT; Pham TT; Ta TT; Tran TN; Nguyen TT; Pham TP; Kyle D; Day NP; White NJ
Trans R Soc Trop Med Hyg; 1997; 91(2):195-8. PubMed ID: 9196768
[TBL] [Abstract][Full Text] [Related]
10. Artesunate and dihydroartemisinin (DHA): unusual decomposition products formed under mild conditions and comments on the fitness of DHA as an antimalarial drug.
Haynes RK; Chan HW; Lung CM; Ng NC; Wong HN; Shek LY; Williams ID; Cartwright A; Gomes MF
ChemMedChem; 2007 Oct; 2(10):1448-63. PubMed ID: 17694524
[TBL] [Abstract][Full Text] [Related]
11. Predicting the Disposition of the Antimalarial Drug Artesunate and Its Active Metabolite Dihydroartemisinin Using Physiologically Based Pharmacokinetic Modeling.
Arey R; Reisfeld B
Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33361307
[TBL] [Abstract][Full Text] [Related]
12. A pharmacokinetic and pharmacodynamic study of artesunate for vivax malaria.
Batty KT; Le AT; Ilett KF; Nguyen PT; Powell SM; Nguyen CH; Truong XM; Vuong VC; Huynh VT; Tran QB; Nguyen VM; Davis TM
Am J Trop Med Hyg; 1998 Nov; 59(5):823-7. PubMed ID: 9840605
[TBL] [Abstract][Full Text] [Related]
13. Comparative bioavailability of oral, rectal, and intramuscular artemether in healthy subjects: use of simultaneous measurement by high performance liquid chromatography and bioassay.
Teja-Isavadharm P; Nosten F; Kyle DE; Luxemburger C; Ter Kuile F; Peggins JO; Brewer TG; White NJ
Br J Clin Pharmacol; 1996 Nov; 42(5):599-604. PubMed ID: 8951191
[TBL] [Abstract][Full Text] [Related]
14. The influence of pregnancy on the pharmacokinetic properties of artemisinin combination therapy (ACT): a systematic review.
Burger RJ; Visser BJ; Grobusch MP; van Vugt M
Malar J; 2016 Feb; 15():99. PubMed ID: 26891915
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of artemisinin-type compounds.
Navaratnam V; Mansor SM; Sit NW; Grace J; Li Q; Olliaro P
Clin Pharmacokinet; 2000 Oct; 39(4):255-70. PubMed ID: 11069212
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of rectal artesunate compared with parenteral quinine in initial treatment of moderately severe malaria in African children and adults: a randomised study.
Barnes KI; Mwenechanya J; Tembo M; McIlleron H; Folb PI; Ribeiro I; Little F; Gomes M; Molyneux ME
Lancet; 2004 May; 363(9421):1598-605. PubMed ID: 15145633
[TBL] [Abstract][Full Text] [Related]
17. [Protective effects of artesunate combination on experimental cerebral malaria and nerve injury].
Jiang XH; Chen LN; Li K; Guo Y; Zheng ZY; Yang T; Zheng XJ; Li YJ; Zhu XX
Zhongguo Zhong Yao Za Zhi; 2018 Aug; 43(15):3051-3057. PubMed ID: 30200698
[TBL] [Abstract][Full Text] [Related]
18. Severe embryolethality of artesunate related to pharmacokinetics following intravenous and intramuscular doses in pregnant rats.
Li Q; Si Y; Xie L; Zhang J; Weina P
Birth Defects Res B Dev Reprod Toxicol; 2009 Oct; 86(5):385-93. PubMed ID: 19851989
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic profiles of artesunate after single intravenous doses at 0.5, 1, 2, 4, and 8 mg/kg in healthy volunteers: a phase I study.
Li Q; Cantilena LR; Leary KJ; Saviolakis GA; Miller RS; Melendez V; Weina PJ
Am J Trop Med Hyg; 2009 Oct; 81(4):615-21. PubMed ID: 19815876
[TBL] [Abstract][Full Text] [Related]
20. Artesunate. A review of its pharmacology and therapeutic efficacy in the treatment of malaria.
Barradell LB; Fitton A
Drugs; 1995 Oct; 50(4):714-41. PubMed ID: 8536555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
